Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral iron challenge and urinary hepcidin in hereditary hemochromatosis
2007-003074-26Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ferrous sulfate in hereditary hemochromatosis (HH), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Short-term urinary hepcidin response to oral iron challenge. Started Jun 2007; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
hereditary hemochromatosis (HH)
Beyond the preview
Go deeper on 2007-003074-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003074-26.